Drug news
Generic Dacogen launched in USA
Dr. Reddy's Laboratories announced that it has launched Decitabine for Injection (50mg) a therapeutic equivalent generic version of Dacogen from Janssen Cilag /Eisai, in the US market on July 11, 2013, following the approval by the FDA of Dr. Reddy's ANDA for Decitabine for Injection.
Dacogen has U.S. sales of approximately $260 Million for the twelve months ending in July 2013 according to IMS Health.